Jagsonpal Pharma skyrockets 14% after entering into agreement with Suvinys Developers

18 Feb 2022 , 12:58 PM

Jagsonpal Pharmaceuticals Limited has entered into an agreement with Suvinys Developers Private Limited for the Supply of Product Dydrogesterone. Suvinys Developers will supply Dydrogesterone to Jagsonpal Pharma as per the terms and conditions mentioned in the agreement.

The company stock saw huge buying activity on Friday despite volatile trade. At around 1.00 pm, Jagsonpal Pharmaceuticals Ltd was trading at Rs201.30 per piece up by Rs23.95 or 13.5% from its previous closing of Rs177.35 per piece on the BSE.

The scrip opened at Rs177.35 and has touched a fresh 52-week high of Rs206.65 and low of Rs175.20 respectively.

The company last week reported a total income of Rs56.4275 crore during the period ended December 31, 2021, as compared to Rs.57.6391 crore during the period ended December 31, 2020. It posted a net profit of Rs5.4065 crore for the period ended December 31, 2021, as against a net profit of Rs5.4303 crore for the period ended December 31, 2020.